Download Free The Biotechnology Debate Book in PDF and EPUB Free Download. You can read online The Biotechnology Debate and write the review.

In this provocative anthology, scholars consider the meaning and merits of “nature” in debates about biotechnology and the environment. Drawing on philosophy, religion, and political science, this book asks what the term “nature” means, how it should be considered, and if it is—even in part—a social construct. The contributors question if the quality of being “natural” is intrinsically valuable. They also discuss whether appeals to nature can and should affect public policy and, if so, whether they are moral trump cards or should instead be weighed against other concerns. Though consensus on these questions remains elusive, this should not be an obstacle to moving the debate forward. By bringing together disparate approaches to addressing these concepts, The Ideal of Nature suggests the possibility of intermediate positions that move beyond the usual full-throated defense and blanket dismissal found in much of the debate. Scholars of bioethics, environmental philosophy, religious studies, sociology, public policy, and political theory will find much merit in this book’s lively discussion.
This revised edition updates Thompson’s trail-blazing study of ethical and philosophical issues raised by biotechnology. The 1997 book was the first by a philosopher to address food and agricultural biotechnology, discussing ethical issues associated with risk assessment, labelling, animal transformation, patents, and impact on traditional farming communities. The new edition addresses the debates of the intervening decade, including cloning, the Precautionary Principle, and the biotechnology debate between the United States and Europe.
The often-confrontational debate over the development of agricultural and pharmaceutical products made with the help of genetic modification has drastically limited the exploitation of this still new technology. This book focuses on the risk and rewards of genetic modification, the differing paths the dialogue on GM has followed in Europe and the developing world in contrast to the United States, how the debate impacts the commercial realities of companies developing new products, and what strategies might foster more constructive discussion over the costs and benefits of genetic manipulation to bring about more rational and internationally coordinated public policy.
This book grounds deliberative democratic theory in a more refined understanding of deliberative practice, in particular when dealing with intractable moral disagreement regarding novel technologies. While there is an ongoing, vibrant debate about the theoretical merits of deliberative democracy on the one hand, and more recently, empirical studies of specific deliberative exercises have been carried out, these two discussions fail to speak to one another. Debates about animal and plant biotechnology are examined as a paradigmatic case for intractable disagreement in today’s pluralistic societies. This examination reveals that the disagreements in this debate are multi-faceted and multi-dimensional and can often be traced to fundamental disagreements about values or worldviews. “One of the acute insights to emerge from this examination is that deliberation can serve different purposes vis-à-vis different types of problem. In the case of deeply unstructured problems, like the modern biotechnology debate, the aim of inclusion is more appropriate than the aim of consensus. This book highlights the importance of political culture and broader institutional settings in shaping the capacity and propensity of citizens to engage in deliberation and the degree to which governments are prepared to relinquish authority to deliberative mini-publics." Robyn Eckersley, University of Melbourne, Australia
Breakthroughs in genetics present us with a promise and a predicament. The promise is that we will soon be able to treat and prevent a host of debilitating diseases. The predicament is that our newfound genetic knowledge may enable us to manipulate our nature—to enhance our genetic traits and those of our children. Although most people find at least some forms of genetic engineering disquieting, it is not easy to articulate why. What is wrong with re-engineering our nature? The Case against Perfection explores these and other moral quandaries connected with the quest to perfect ourselves and our children. Michael Sandel argues that the pursuit of perfection is flawed for reasons that go beyond safety and fairness. The drive to enhance human nature through genetic technologies is objectionable because it represents a bid for mastery and dominion that fails to appreciate the gifted character of human powers and achievements. Carrying us beyond familiar terms of political discourse, this book contends that the genetic revolution will change the way philosophers discuss ethics and will force spiritual questions back onto the political agenda. In order to grapple with the ethics of enhancement, we need to confront questions largely lost from view in the modern world. Since these questions verge on theology, modern philosophers and political theorists tend to shrink from them. But our new powers of biotechnology make these questions unavoidable. Addressing them is the task of this book, by one of America’s preeminent moral and political thinkers.
Between 1973 and 2016, the ways to manipulate DNA to endow new characteristics in an organism (that is, biotechnology) have advanced, enabling the development of products that were not previously possible. What will the likely future products of biotechnology be over the next 5â€"10 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology? Preparing for Future Products of Biotechnology analyzes the future landscape of biotechnology products and seeks to inform forthcoming policy making. This report identifies potential new risks and frameworks for risk assessment and areas in which the risks or lack of risks relating to the products of biotechnology are well understood.
This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics.
"This brief textbook of human development covers the events of fertilization, gestation, and sex determination, followed by descriptions of the science of cloning, stem cells, and genome sequencing. The chapter covering the science is juxtaposed with a chapter discussing ethical questions that arise, such as when does life begin, should assisted reproductive technologies be regulated, and should parents be allowed to choose their child's sex"--Provided by publisher.
This history of the scientific and commercial lines of plant development in the United States traces the transformation of the seed from a public good produced and reproduced by farmers into a commodity controlled by businesses and corporations divorced from the uses of their product.
In Animals as Biotechnology sociologist Richard Twine places the question of human/animal relations at the heart of sustainability and climate change debates. The book is shaped by the emergence of two contradictory trends within our approach to nonhuman animals: the biotechnological turn in animal sciences, which aims to increase the efficiency and profitability of meat and dairy production; and the emerging field of critical animal studies - mostly in the humanities and social sciences - which works to question the nature of our relations with other animals. The first part of the book focuses on ethics, examining critically the dominant paradigms of bioethics and power relations between human and non-human. The second part considers animal biotechnology and political economy, examining commercialisation and regulation. The final part of the book centres on discussions of sustainability, limits and an examination of the prospects for animal ethics if biotechnology becomes part of the dominant agricultural paradigm. Twine concludes by considering whether growing calls to reduce our consumption of meat/dairy products in the face of climate change threats are in fact complicit with an anthropocentric understanding of sustainability and that what is needed is a more fundamental ethical and political questioning of relations and distinctions between humans, animals and nature.